Molecular Analysis for Therapy Choice (MATCH)
- Result Type
- clinical trial
This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas.
Status: Active, Recruiting
3results found for:
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Result Type
- clinical trial
To learn real world practice of prescribing targeted therapies to patients with advanced cancers.
Solid Tumors, Lymphoma, & Rare Cancers (ECOG EAY131)
- Result Type
- clinical trial
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Status: Active, Recruiting